Search Results

Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)

• Authors : Loffeler, S; Bertilsson, H; Muller, C

Subjects: Medicin och hälsovetenskap

• Source: BJU international. 133(6):680-689

Record details

Origin and outcome of metastatic tumours to the testes: a nationwide study.

• Authors : Woortman, Carmen¹ (AUTHOR) ; van Leenders, Geert J. L. H.² (AUTHOR); Hugen, Niek³ (AUTHOR)

• Source: BJU International. Mar2024, Vol. 133 Issue 3, p305-313. 9p.

Record details

The immune‐related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trials.

• Authors : Robesti, Daniele^1,2 (AUTHOR); Nocera, Luigi^1,2 (AUTHOR); Belladelli, Federico^1,2 (AUTHOR)

• Source: BJU International. Feb2024, Vol. 133 Issue 2, p158-168. 11p.

Record details

Localised non‐metastatic sarcomatoid renal cell carcinoma: a 31‐year externally verified study.

• Authors : Blum, Kyle A.¹ (AUTHOR); Silagy, Andrew W.¹ (AUTHOR); Knezevic, Andrea² (AUTHOR)

• Source: BJU International. Feb2024, Vol. 133 Issue 2, p169-178. 10p.

Record details

Poly(adenosine diphosphate‐ribose) polymerase inhibitor combinations in first‐line metastatic castrate‐resistant prostate cancer setting: a systematic review and meta‐analysis.

• Authors : Sayyid, Rashid K.¹ (AUTHOR) ; Klaassen, Zachary² (AUTHOR); Berlin, Alejandro^3,4 (AUTHOR)

• Source: BJU International. Dec2023, Vol. 132 Issue 6, p619-630. 12p.

Record details

Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation.

• Authors : De, Brian¹ (AUTHOR); Venkatesan, Aradhana M.² (AUTHOR); Msaouel, Pavlos^3,4 (AUTHOR)

• Source: BJU International. May2022, Vol. 129 Issue 5, p610-620. 11p.

Record details

Prostate‐specific membrane antigen positron emission tomography‐computed tomography use prior to systemic therapy in metastatic castration‐resistant prostate cancer.

• Authors : Kelly, Richard^1,2 (AUTHOR) ; Jensen, Andrew³ (AUTHOR); Karunaratna, Nathasha⁴ (AUTHOR)

• Source: BJU International. Feb2023, Vol. 131 Issue 2, p179-182. 4p.

Record details

Non‐metastatic muscle‐invasive bladder cancer: the role of age in receiving treatment with curative intent.

• Authors : van Hoogstraten, Lisa M.C.^1,2 (AUTHOR) ; Witjes, J. Alfred³ (AUTHOR); Meijer, Richard P.⁴ (AUTHOR)

• Source: BJU International. Dec2022, Vol. 130 Issue 6, p764-775. 12p.

Record details

The Triple‐Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol.

• Authors : Pouliot, Frédéric^1,2 (AUTHOR) ; Beauregard, Jean‐Mathieu^1,3,4 (AUTHOR) ; Saad, Fred⁵ (AUTHOR)

• Source: BJU International. Sep2022, Vol. 130 Issue 3, p314-322. 9p.

Record details

Prognostic importance of concomitant non‐regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer.

• Authors : Heesterman, Berdine L.¹ (AUTHOR) ; van der Poel, Henk G.² (AUTHOR); Schoots, Ivo G.^3,4 (AUTHOR)

• Source: BJU International. Aug2022, Vol. 130 Issue 2, p217-225. 9p.

Record details